Mindfulness Program Beneficial for Chronic Pain

This article originally appeared here.
Share this content:
Mindfulness Program Beneficial for Chronic Pain
Mindfulness Program Beneficial for Chronic Pain

(HealthDay News) -- A mindfulness program appears to be beneficial for patients with chronic pain, according to a study published in the April issue of Pain Medicine.

Peter la Cour, Ph.D., from the Copenhagen Multidisciplinary Pain Center, and Marian Peterson, Ph.D., from the Neuroscience Center at Rigshospitalet -- both in Denmark, conducted a randomized trial to examine the effects of mindfulness meditation on chronic pain. Patients with nonspecific chronic pain were randomly allocated to a standardized mindfulness meditation program (mindfulness-based stress reduction [MBSR]; 43 patients) or wait list control (47 patients). The primary outcome measure was the Short-Form 36 (SF36) vitality scale. Data were compared at baseline, after completion of the course/waiting period, and at the six-month follow-up.

The researchers observed a significant effect on the primary outcome measure (Cohen's d = 0.39). Significant medium to large effects were seen on the secondary variables, including lower general anxiety and depression, better mental quality of life, feeling in control of the pain, and higher pain acceptance. For pain measures, small, nonsignificant effect sizes were observed. Measures just after the intervention were not significantly different from those at the six-month follow-up.

"A standardized mindfulness program contributes positively to pain management and can exert clinically relevant effects on several important dimensions in patients with long-lasting chronic pain," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Plan to Relax Coal-Fired Power Plant Rules Could Up Mortality

Plan to Relax Coal-Fired Power Plant Rules Could ...

EPA predicts between 470 and 1,400 premature deaths a year by 2030

FDA Extends EpiPen Expiration Dates to Tackle Shortage

FDA Extends EpiPen Expiration Dates to Tackle Shortage

Shortages due to factors such as supply disruptions and manufacturer issues

USPSTF Updates Guidance for Cervical Cancer Screening

USPSTF Updates Guidance for Cervical Cancer Screening

Cytology recommended every three years from age 21; different screening options from age 30 to 65

is free, fast, and customized just for you!




Already a member?

Sign In Now »